Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | -2.56%110.96M | -19.37%192.58M | -6.53%113.87M | 14.63%238.83M | -5.74%121.83M | -17.45%208.35M | --129.25M | 44.12%252.4M | ---- | 35.82%175.14M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | 17.97%-14.39M | 11.36%-33.78M | 1.09%-17.55M | -4.81%-38.1M | -3.40%-17.74M | -34.10%-36.36M | ---17.16M | -1,717.16%-27.11M | ---- | -29.97%-1.49M |
| Attributable subsidiary (profit) loss | ---- | -99.54%74K | -99.08%74K | -22.99%16.08M | -19.84%8.05M | 955.84%20.87M | --10.05M | --1.98M | ---- | ---- |
| Impairment and provisions: | -45.41%707K | 112.10%1.15M | 154.05%1.3M | -144.25%-9.48M | -146.32%-2.4M | 108.03%21.42M | --5.17M | 181.87%10.29M | ---- | -13.97%3.65M |
| -Other impairments and provisions | -45.41%707K | 112.10%1.15M | 154.05%1.3M | -144.25%-9.48M | -146.32%-2.4M | 108.03%21.42M | --5.17M | 181.87%10.29M | ---- | -13.97%3.65M |
| Revaluation surplus: | ---- | 110.56%120K | ---- | -3,957.14%-1.14M | ---- | -103.04%-28K | ---- | 200.00%920K | ---- | 7.54%-920K |
| -Other fair value changes | ---- | 110.56%120K | ---- | -3,957.14%-1.14M | ---- | -103.04%-28K | ---- | 200.00%920K | ---- | 7.54%-920K |
| Asset sale loss (gain): | --131K | 100.71%3K | ---- | -2,010.00%-422K | ---300K | -186.96%-20K | ---- | -82.17%23K | ---- | 102.93%129K |
| -Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---300K | ---300K | ---- | ---- | ---- | ---- | ---- |
| -Loss (gain) on sale of property, machinery and equipment | --131K | 102.46%3K | ---- | -510.00%-122K | ---- | -186.96%-20K | ---- | -82.17%23K | ---- | --129K |
| Depreciation and amortization: | -1.29%23.38M | 0.33%46.69M | 6.92%23.69M | 70.12%46.54M | 259.74%22.15M | 273.14%27.36M | --6.16M | -0.84%7.33M | ---- | 83.86%7.39M |
| -Depreciation | -48.72%300K | -76.93%961K | -72.41%585K | -11.12%4.17M | 6.85%2.12M | 14.26%4.69M | --1.98M | -1.16%4.1M | ---- | 200.00%4.15M |
| Financial expense | 1.69%18.45M | -4.85%36.43M | -4.98%18.14M | 64.02%38.29M | 312.13%19.09M | 503.31%23.34M | --4.63M | -6.66%3.87M | ---- | 31.59%4.15M |
| Special items | -4.75%561K | -22.00%592K | -31.43%589K | 377.01%759K | 388.07%859K | -103.43%-274K | --176K | -28.52%7.99M | ---- | 2,162.55%11.18M |
| Operating profit before the change of operating capital | -0.23%139.79M | -16.30%243.86M | -7.55%140.11M | 10.09%291.35M | 9.60%151.55M | 2.70%264.65M | --138.28M | 29.35%257.69M | ---- | 48.33%199.22M |
| Change of operating capital | ||||||||||
| Accounts receivable (increase)decrease | 33.82%-6.33M | -165.42%-18.7M | -138.97%-9.57M | 186.50%28.58M | 195.38%24.54M | -92.39%-33.05M | ---25.73M | -24.54%-17.18M | ---- | -523.98%-13.79M |
| Accounts payable increase (decrease) | -224.39%-54.8M | -86.92%7M | -75.80%-16.89M | 2,080.05%53.5M | 73.51%-9.61M | -134.55%-2.7M | ---36.28M | 265.77%7.82M | ---- | 30.75%-4.72M |
| Special items for working capital changes | 102.36%86K | 86.94%-459K | -35.89%-3.65M | -144.56%-3.51M | -125.27%-2.69M | -1.38%7.89M | --10.63M | 241.90%8M | ---- | -175.09%-5.64M |
| Cash from business operations | -28.41%78.75M | -37.37%231.7M | -32.84%110M | 56.22%369.92M | 88.49%163.8M | -7.62%236.79M | --86.9M | 46.41%256.33M | ---- | 26.64%175.07M |
| Other taxs | -5.84%-40.47M | 10.05%-63.71M | 7.52%-38.23M | 5.74%-70.83M | 11.17%-41.34M | -32.14%-75.14M | ---46.55M | -36.47%-56.86M | ---- | -48.95%-41.67M |
| Special items of business | -11.02%105K | -8.76%229K | --118K | -8.39%251K | ---- | -6.16%274K | ---- | 13.62%292K | 96.82%46.18M | 93.23%257K |
| Net cash from operations | -46.61%38.38M | -43.80%168.22M | -41.30%71.89M | 84.86%299.34M | 203.45%122.46M | -18.94%161.93M | -12.62%40.35M | 49.45%199.76M | 96.82%46.18M | 21.06%133.67M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | -83.74%5.28M | 124.45%54.31M | 329.60%32.49M | -18.31%24.2M | -55.43%7.56M | 218.32%29.62M | 256.19%16.97M | 63.75%9.31M | 141.09%4.76M | -59.56%5.68M |
| Restricted cash (increase) decrease | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Loan receivable (increase) decrease | ---- | ---- | ---- | -270.37%-15M | ---15M | 73.00%-4.05M | ---- | ---15M | ---- | ---- |
| Decrease in deposits (increase) | 27.58%-205.79M | 370.13%187.07M | -242.35%-284.17M | -251.93%-69.25M | -159.90%-83.01M | 105.65%45.58M | 117.97%138.58M | ---806.41M | ---771.34M | ---- |
| Sale of fixed assets | ---- | -99.44%1K | ---- | 9.09%180K | --53K | --165K | ---- | ---- | ---- | ---- |
| Purchase of fixed assets | 84.88%-57K | 58.54%-539K | 22.59%-377K | 68.22%-1.3M | -48.02%-487K | 76.23%-4.09M | 2.37%-329K | -825.82%-17.21M | 75.79%-337K | -230.20%-1.86M |
| Sale of subsidiaries | ---- | ---- | ---- | -244.42%-3.05M | ---3.05M | --2.11M | ---- | ---- | ---- | ---- |
| Recovery of cash from investments | ---- | --21.02M | --21.14M | ---- | ---- | -98.91%2.02M | ---- | -71.17%185M | -35.41%186.01M | -35.37%641.79M |
| Cash on investment | ---- | ---- | ---- | -600.00%-35M | -80.23%-35M | 78.07%-5M | -654.76%-19.42M | 97.01%-22.8M | 99.24%-2.57M | 2.58%-762.78M |
| Other items in the investment business | 4.41%-39.17M | -34.03%-71.53M | -122.87%-40.97M | 24.38%-53.37M | ---18.38M | ---70.58M | ---- | ---- | ---- | ---- |
| Net cash from investment operations | 11.83%-239.73M | 224.73%190.34M | -84.57%-271.89M | -3,519.45%-152.6M | -208.48%-147.31M | 99.37%-4.22M | 123.27%135.8M | -469.35%-667.12M | -1,035.05%-583.48M | -152.61%-117.17M |
| Net cash before financing | -0.67%-201.35M | 144.34%358.55M | -704.63%-200.01M | -6.95%146.75M | -114.11%-24.86M | 133.75%157.71M | 132.78%176.15M | -2,933.50%-467.36M | -1,822.91%-537.3M | -95.05%16.49M |
| Cash flow from financing activities | ||||||||||
| New borrowing | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --1.44M |
| Refund | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---1.44M | ---- | ---- |
| Issuing shares | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --873.64M | --873.64M | ---- |
| Interest paid - financing | -87.34%-1.33M | -34.08%-1.63M | -24.08%-711K | -3.95%-1.21M | -14.37%-573K | 69.86%-1.17M | 74.86%-501K | 6.66%-3.87M | 4.96%-1.99M | -31.59%-4.15M |
| Dividends paid - financing | ---- | -153.98%-164.59M | ---- | 45.57%-64.8M | ---- | -135.41%-119.05M | ---- | ---50.57M | ---- | ---- |
| Absorb investment income | ---- | ---- | ---- | ---- | ---- | 0.00%15M | --15M | --15M | ---- | ---- |
| Issuance expenses and redemption of securities expenses | ---- | 87.95%-595K | 22.86%-894K | -44.36%-4.94M | 46.47%-1.16M | 93.90%-3.42M | 96.24%-2.17M | -1,555.70%-56.03M | -2,135.39%-57.54M | -55.23%-3.38M |
| Net cash from financing operations | 17.39%-11.64M | -127.33%-194.87M | -88.84%-14.09M | 27.46%-85.72M | -199.26%-7.46M | -115.31%-118.17M | -99.07%7.52M | 8,930.46%772.05M | 15,584.07%811.83M | 96.94%-8.74M |
| Net Cash | 0.52%-212.99M | 168.22%163.69M | -562.44%-214.1M | 54.34%61.03M | -117.60%-32.32M | -87.02%39.54M | -33.10%183.67M | 3,830.96%304.69M | 927.27%274.53M | -83.52%7.75M |
| Begining period cash | 29.93%710.6M | 12.56%546.91M | 12.56%546.91M | 8.86%485.89M | 8.86%485.89M | 215.08%446.35M | 215.08%446.35M | 5.79%141.66M | 5.79%141.66M | 54.16%133.91M |
| Cash at the end | 49.52%497.61M | 29.93%710.6M | -26.62%332.82M | 12.56%546.91M | -28.01%453.57M | 8.86%485.89M | 51.38%630.02M | 215.08%446.35M | 313.20%416.19M | 5.79%141.66M |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.